Key result
Intra-aortic balloon counterpulsation suppressed medically refractory ventricular arrhythmia in 18 of 21 patients (85.7%), with 95% overall survival at a mean follow-up of 25.7 months.
Why the study?
Does intra-aortic balloon counterpulsation improve arrhythmia suppression and survival in patients with medically refractory ventricular arrhythmia?
Observational (n=21)
No
Does intra-aortic balloon counterpulsation improve arrhythmia suppression and survival in patients with medically refractory ventricular arrhythmia?
Intra-aortic balloon counterpulsation can effectively suppress medically refractory ventricular arrhythmia in patients with severe left ventricular impairment, serving as a bridge to definitive medical or surgical therapy.
Answers are grounded in this paper and cite their sources.
May support IABP as bridge in refractory ventricular arrhythmia with severe LV impairment; hypothesis-generating, needs randomized confirmation.
OBJECTIVE To review the efficacy of intra-aortic balloon counterpulsation (IABCP) in medically refractory ventricular arrhythmia. DESIGN Retrospective analysis of the outcome of patients with ventricular arrhythmia treated with IABCP after transfer between 1992 and 1997. SETTING Tertiary cardiac referral centre. PATIENTS 21 patients (mean age 58 years) who underwent IABCP for control of ventricular arrhythmia. All had significant left ventricular impairment (mean ejection fraction 28.6%); 18 had coronary artery disease. RESULTS Before IABCP, 10 patients had incessant monomorphic ventricular tachycardia and 11 had paroxysmal ventricular tachycardia and/or ventricular fibrillation (VT/VF). IABCP resulted in suppression of ventricular arrhythmia in 18 patients, of whom 13 were weaned from IABCP. After stabilisation of ventricular arrhythmia, 10 patients were maintained on medical treatment alone and one underwent endocardial resection. IABCP was maintained until cardiac transplantation in five patients. One patient had a fatal arrest before discharge and one died from progressive heart failure. IABCP failed to control ventricular arrhythmia in three patients and was subsequently discontinued. A cardiac assist device was employed in one of these until cardiac transplantation; the other two were eventually stabilised on medical treatment. Nineteen patients were discharged from hospital. Overall survival was 95% at mean follow up of 25.7 months. CONCLUSIONS IABCP can be an effective means of controlling refractory ventricular arrhythmia, allowing time for the institution of more definitive treatment.
No takes yet. Share an insight, caveat, or question.
Fotopoulos et al. (1999) conducted an observational in Medically refractory ventricular arrhythmia (n=21). Intra-aortic balloon counterpulsation (IABCP) was evaluated on Suppression of ventricular arrhythmia. Intra-aortic balloon counterpulsation suppressed medically refractory ventricular arrhythmia in 18 of 21 patients (85.7%), with 95% overall survival at a mean follow-up of 25.7 months.
Synapse has enriched 10 related papers. Consider them for comparative context: